US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Aridis Pharmaceuticals Inc (CE) (ARDS)
Aridis Pharmaceuticals Inc (CE) (ARDS) ニュース

ARDS

Aridis Pharmaceuticals (CE) (ARDS)

Aridis Pharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ARDS

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/12/18	23 : 43	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/12/18	23 : 40	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/12/16	07 : 00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/11/07	06 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/09/20	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/09/20	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/09/20	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/09/20	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/08/10	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2023/07/27	03 : 56	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2020/01/29	07 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2020/01/14	06 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2020/01/14	05 : 48	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2020/01/03	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2019/12/31	04 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2019/11/14	06 : 33	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)
2019/11/14	06 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ARDS	Aridis Pharmaceuticals Inc (CE)

Showing the most relevant articles for your search:USOTC:ARDS

1

Cidara Therapeutics

BNP Paribas Issuance

Alnylam Pharmaceuticals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約